Harvard Bioscience, Inc. (HBIO)
9.37
+0.28
(+3.08%)
USD |
NASDAQ |
Nov 10, 16:00
9.37
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Cash from Operations (Annual) : 6.729M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 6.729M |
| December 31, 2024 | 1.44M |
| December 31, 2023 | 14.03M |
| December 31, 2022 | 1.152M |
| December 31, 2021 | 1.262M |
| December 31, 2020 | 9.331M |
| December 31, 2019 | 8.045M |
| December 31, 2018 | 2.884M |
| December 31, 2017 | 1.057M |
| December 31, 2016 | 5.383M |
| December 31, 2015 | 0.705M |
| December 31, 2014 | 4.351M |
| December 31, 2013 | 4.06M |
| December 31, 2012 | 8.062M |
| December 31, 2011 | 6.648M |
| Date | Value |
|---|---|
| December 31, 2010 | 12.29M |
| December 31, 2009 | 16.51M |
| December 31, 2008 | 9.202M |
| December 31, 2007 | 12.06M |
| December 31, 2006 | 8.356M |
| December 31, 2005 | 5.195M |
| December 31, 2004 | 11.44M |
| December 31, 2003 | 2.028M |
| December 31, 2002 | 0.799M |
| December 31, 2001 | 4.095M |
| December 31, 2000 | 2.146M |
| December 31, 1999 | 2.926M |
| December 31, 1998 | 1.806M |
| December 31, 1997 | 1.116M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Agilent Technologies, Inc. | 1.559B |
| Bio-Rad Laboratories, Inc. | 532.20M |
| Bruker Corp. | 134.10M |
| Danaher Corp. | 6.416B |
| Illumina, Inc. | 1.079B |